Invitae Wants Myriad's Gene-Testing Patent Suit Tossed

Law360, New York (December 10, 2013, 10:28 PM EST) -- Genetic testing company Invitae Corp. asked a Utah federal court Monday to throw out Myriad Genetics Inc.’s suit alleging Invitae infringed on its patents relating to genetic screening for breast cancer, saying the court lacks jurisdiction because Invitae has no contacts in Utah.

Invitae’s motion asserts that although the patent infringement suit by Utah-based Myriad would fail on its merits, the court should dismiss it immediately because it lacks jurisdiction over San Francisco-based Invitae. Invitae argues it cannot be sued in Utah because it does not...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.